Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Is COVID-19 A Preexisting Condition For Which Americans Could Lose Coverage? Some Senators Say So

Other senators at hearing call CDC advice unclear on if asymptomatic people with close contacts to those infected should get testing

Executive Summary

US Senators said Wednesday coronavirus patients could lose coverage if the ACA is abolished by a new Supreme Court, while Sen. Warren accused a COVID-19 response advisor of conflicts of interest.

You may also be interested in...



Senate HELP Committee Plans Work To Raise Minimum Wage, Stop COVID-19

Senate HELP Committee chair Patty Murray’s priorities are legislation to raise the minimum wage and getting the US COVID-19 response on track.

GAO To Investigate Trump Admin Attacks On Scientific Integrity At FDA, CDC

The US watchdog agency accedes to three senators’ request to look into political pressures placed on the FDA and the CDC to alter the science behind their COVID-19 responses.

Legal Experts Predict How US Supreme Court Shake-Up Will Impact Medtech

If President Donald Trump appoints, and the Senate approves, a new conservative justice for the Supreme Court to replace Ruth Bader Ginsburg, Affordable Care Act coverage could disappear. Two legal experts weigh in on this and other legal issues that could touch the medical device industry.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT142792

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel